Effect of buckminsterfullerenes on cells of the innate and adaptive immune system: an in vitro study with human peripheral blood mononuclear cells

References

• KrotoHWHeathJRO’BrienSCCurlRFSmalleyREC60: BuckminsterfullereneNature1985318162163
   Web of Science ®Google Scholar
• KrotoHWAllafAWBalmSPC60: buckminsterfullereneChem Rev19919112131235
   Web of Science ®Google Scholar
• LeeVSNimmanpipugPAruksakunwongOPromsriSSompornpisutPHannongbuaSStructural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulationsJ Mol Graph Model200726255857017468026
   PubMed Web of Science ®Google Scholar
• BakryRVallantRMNajam-ul-HaqMMedicinal applications of fullerenesInt J Nanomedicine20072463964918203430
   PubMed Web of Science ®Google Scholar
• BosiSDa RosTSpallutoGPratoMFullerene derivatives: an attractive tool for biological applicationsEur J Med Chem20033811–1291392314642323
   PubMed Web of Science ®Google Scholar
• LeeJMahendraSAlvarezPJNanomaterials in the construction industry: a review of their applications and environmental healthy and safety considerationsACS Nano2010473580359020695513
   PubMed Web of Science ®Google Scholar
• MashinoTShimotohnoKIkegamiNHuman immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivativesBioorg Med Chem Lett20051541107110915686922
   PubMed Web of Science ®Google Scholar
• BosiSDa RosTCastellanoSBanfiEPratoMAntimycobacterial activity of ionic fullerene derivativesBioorg Med Chem Lett200010101043404510843212
   PubMed Web of Science ®Google Scholar
• FriedmanSHDeCampDLSijbesmaRPSrdanovGWudlFKenyonGLInhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verificationJ Am Chem Soc19931151565066509
   Web of Science ®Google Scholar
• DurdagiSMavromoustakosTChronakisNPapadopoulosMGComputational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulationsBioorg Med Chem200816239957997418996019
   PubMed Web of Science ®Google Scholar
• IbrahimMSalehNAHameedAJElshemeyWMElsayedAAStructural and electronic properties of new fullerene derivatives and their possible application as HIV-1 protease inhibitorsSpectrochim Acta A Mol Biomol Spectrosc201075270270920044306
   PubMed Web of Science ®Google Scholar
• NielsenGDRoursgaardMJensenKAPoulsenSSLarsenSTIn vivo biology and toxicology of fullerenes and their derivativesBasic Clin Pharmacol Toxicol2008103319720818684229
   PubMed Web of Science ®Google Scholar
• KolosnjajJSzwarcHMoussaFToxicity studies of fullerenes and derivativesAdv Exp Med Biol200762016818018217343
   PubMed Web of Science ®Google Scholar
• YamawakiHIwaiNCytotoxicity of water-soluble fullerene in vascular endothelial cellsAm J Physiol Cell Physiol20062906C1495C150216407415
   PubMed Web of Science ®Google Scholar
• IsakovicAMarkovicZTodorovic-MarkovicBDistinct cytotoxic mechanisms of pristine versus hydroxylated fullereneToxicol Sci200691117318316476688
   PubMed Web of Science ®Google Scholar
• SayesCMGobinAMAusmanKDMendezJWestJLColvinVLNano-C60 cytotoxicity is due to lipid peroxidationBiomaterials200526367587759516005959
   PubMed Web of Science ®Google Scholar
• LiuYJiaoFQiuYImmunostimulatory properties and enhanced TNF-α mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticlesNanotechnology200914;2041415102
   Web of Science ®Google Scholar
• MontanezMIRuiz-SanchezAJPerez-InestrosaEA perspective of nanotechnology in hypersensitivity reactions including drug allergyCurr Opin Allergy Clin Immunol201010429730220485158
   PubMed Web of Science ®Google Scholar
• YangDZhaoYGuoH[Gd@C82(OH)22]n nanoparticles induce dendritic cell maturation and activate Th1 immune responsesACS Nano2010421178118620121217
   PubMed Web of Science ®Google Scholar
• ZhuJJiZWangJTumor-inhibitory effect and immunomodulatory activity of fullerol C60(OH)xSmall2008481168117518574800
   PubMed Web of Science ®Google Scholar
• MoriTTakadaHItoSMatsubayashiKMiwaNSawaguchiTPreclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesisToxicology20062251485416782258
   PubMed Web of Science ®Google Scholar
• YudohKKarasawaRMasukoKKatoTWater-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritisInt J Nanomedicine2009421722519918368
   PubMed Web of Science ®Google Scholar
• PorterAEGassMMullerKSkepperJNMidgleyPWellandMVisualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy-filtered transmission electron microscopy and electron tomographyEnviron Sci Technol20074183012301717533872
   PubMed Web of Science ®Google Scholar
• CalvaresiMZerbettoFBaiting proteins with C60ACS Nano2010442283229920359241
   PubMed Web of Science ®Google Scholar
• BarthHKleinKBörtleinAAnalysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced Th1, relapsing-remitting course with enhanced T H0 reactivityJ Neuroimmunol20021331–217518312446020
   PubMed Web of Science ®Google Scholar
• BarthHBergPAKleinRMethods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigensClin Exp Immunol20031341788512974758
   PubMed Web of Science ®Google Scholar
• ThaherFPlankenhornSKleinRDifferential effects of the tumor necrosis factor alpha-blocker infliximab and etanercept on immunocompetent cells in vitroInt Immunopharmacol201111111724173121704732
   PubMed Web of Science ®Google Scholar
• BarthHKleinRBergPAWiedenmannBHopfUBergTAnalysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infectionHepatogastroenterology2003504920120612630023
   PubMedGoogle Scholar
• KleinRBuckSClassenKRostockMHuberREnhanced in vitro activation of immunocompetent cells in healthy individuals being subcutaneously ‘vaccinated’ with placebo (physiological saline)Clin Immunol2008126332233118345549
   PubMed Web of Science ®Google Scholar
• KleinRSchwenkMHeinrich-RammRTempletonDMDiagnostic relevance of the lymphocyte transformation test for sensitization to beryllium and other metalsPure Appl Chem200476612691281
   Web of Science ®Google Scholar
• KleinRSchwenkMTempletonDMCytokine profiles in human exposure to metals (IUPAC Technical Report)Pure Appl Chem2006781121552168
   Web of Science ®Google Scholar
• KleinREvidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver diseaseEur J Clin Pharmacol200965121195120119641912
   PubMed Web of Science ®Google Scholar
• BrattigNWDiaoGJBergPAThe specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenceEur J Clin Pharmacol198835139453265385
   PubMed Web of Science ®Google Scholar
• RyanJJBatemanHRStoverAFullerene nanomaterials inhibit the allergic responseJ Immunol2007179166567217579089
   PubMed Web of Science ®Google Scholar
• ChomaratPBanchereauJDavoustJPaluckaAKIL-6 switches the differentiation of monocytes from dendritic cells to macrophagesNat Immunol20001651051411101873
   PubMed Web of Science ®Google Scholar
• CaligiuriMAHuman natural killer cellsBlood200811246146918650461
   PubMed Web of Science ®Google Scholar
• DellingerAZhouZLenkRMacFarlandDKepleyCLFullerene nanomaterials inhibit phorbol myristate acetate-induced inflammationExp Dermatol200918121079108119555428
   PubMed Web of Science ®Google Scholar
• DellingerAZhouZNortonSKLenkRConradDKepleyCLUptake and distribution of fullerenes in human mast cellsNanomedicine20106457558220138243
   PubMed Web of Science ®Google Scholar
• HeusinkveldMvan der BurgSHIdentification and manipulation of tumor associated macrophages in human cancersJ Translat Med20119216
   PubMed Web of Science ®Google Scholar
• FrickJSZahirNMullerMColitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6Eur J Immunol20063661537154716708404
   PubMed Web of Science ®Google Scholar
• HedgeSPahneJSmola-HessSNovel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expressionFASEB J200418121439144115247147
   PubMed Web of Science ®Google Scholar
• WehnerRDietzeKBachmannMSchmitzMThe bidirectional crosstalk between human dendritic cells and natural killer cellsJ Innate Immun20113325826321411969
   PubMed Web of Science ®Google Scholar
• AndersenAJHashemiSHAndresenTLHunterACMoghiniSMComplement: alive and kicking nanomedicinesJ Biomed Nanotechnol20095436437220055082
   PubMed Web of Science ®Google Scholar
• FusakioMEMohammedJPLaumonnierYHoebeKKöhlJMattnerJC5a regulates NKT and NK cell functions in sepsisJ Immunol20111875805581222058413
   PubMed Web of Science ®Google Scholar
• QingXKooGCSalmonJEComplement regulates conventional DC-mediated NK-cell activation by inducing TGF-b1 in Gr-1 (+) myeloid cellsEur J Immunol4252012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• MikawaMKatoHOkunuraMParamagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agentsBioconjugate Chem2001124510514
   PubMed Web of Science ®Google Scholar
• LiuYJiaoFQiuYThe effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunityBiomaterials20093023–243934394519403166
   PubMed Web of Science ®Google Scholar
• DumortierHLacotteSPastorinGFunctionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cellsNano Lett2006671522152816834443
   PubMed Web of Science ®Google Scholar
• BiancoAHobekeJGodefroySCationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory propertiesJ Am Chem Soc20051271585915631447
   PubMed Web of Science ®Google Scholar
• AliSSHardtJIQuickKLA biologically effective fullerene (C60) derivative with superoxide dismutase mimetic propertiesFree Radical Biol Med20043781191120215451059
   PubMed Web of Science ®Google Scholar